Aggression - 371 Studies Found

Terminated : A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
: Lymphoma, Non-Hodgkin
: 2010-10-27
:
  • Drug: Inotuzumab ozogamicin 1.
Completed : A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas
:
  • Primary Non-Hodgkin-Lymphoma
  • Refractory Non-Hodgkin-Lymphoma
  • Violent Aggressive Behavior
  • Mediation

: 2017-04-28
: Behavioral: Presence of a mediator in the emergency departments
Recruiting : KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma
: Diffuse Large B-Cell Lymphoma
: 2015-06-11
:
  • Drug: KPT-330 KPT-330 administ
Recruiting : Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza
:
  • Problem Behavior
  • Aggression
  • P
    : 2016-01-26
    : Behavioral: Mind-Body Skills Groups Mind-Body Skills groups consist of small groups of about 8-10 partic
Recruiting : Omega-3 Supplementation and Behavior Problems
:
  • Aggression
  • Antisocial Behavior
  • Dietary Supplement: Omega-3 supplemented drink

Recruiting : Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
:
  • Diffuse Large B-Cell Lymphoma
  • High Grade B-Cell Lymphoma

: 2017-01-27
:
  • Drug: Venetoclax Venetoclax wi
Recruiting : Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
: B-Cell Non Hodgkin Lymphoma
: 2016-08-30
:
  • Drug: Blinatumomab Blinatumoma
<<< Previous | Next >>>